Journal of International Oncology››2012,Vol. 39››Issue (11): 837-839.

Previous ArticlesNext Articles

Poly ADP-ribose polymerase inhibitors in cancer therapy

MA Qiang, HAO Ji-Qing

  1. Department of Medical Oncology, First Hospital of Anhui Medical University , Hefei 230022, China
  • Online:2012-11-08Published:2012-11-16

Abstract:Poly ADP ribose polymerases (PARP) play an important role in DNA damage repair and genome stability. So, PARP inhibitors can inhibit the DNA damage repairing of tumor cells and enhance the sensitivity of the DNA of tumor cells to damage factors. In recent years, PARP inhibitors have been more and more concerned. PARP inhibitors can kill tumor cells with certain genetic mutations alone by synthetic lethal effect. In addition, PARP inhibitors in combination with chemotherapy or radiotherapy can increase the sensitivity of tumor cells to the chemotherapy or radiotherapy. PARP inhibitors are expected to play an important role in cancer therapy.

Key words:Poly(ADP-ribose) polymerases,Enzyme inhibitors,DNA damage,DNA repair enzymes,Neoplasms